Separation of positional CPP isomers by chiral HPLC-DAD of seized tablets

International Journal of Legal Medicine

Volumn 125, Issue 1, 2011, Pages 95-99

  Schürenkamp, Jennifer ^a   Beike, Justus ^b   Pfeiffer, Heidi ^a   Köhler, Helga ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Chiral column; Chlorophenylpiperazine; HPLC DAD; M CPP; Positional isomers

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1-(3-CHLOROPHENYL)PIPERAZINE; DESIGNER DRUG; PIPERAZINE DERIVATIVE; STREET DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERISM; METHODOLOGY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; ISOMERISM; MOLECULAR STRUCTURE; PIPERAZINES; STREET DRUGS;

EID: 78651312613     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-010-0422-z     Document Type: Article

References (25)

1. EMCDDA, Europol (2007) Active Monitoring Report on a new psychoactive substance: 1-(3-chlorophenyl)piperazine (mCPP)-Annex 1 Technical Information. http://www.emcdda.europa.eu/themes/new-drugs/early-warning. Accessed 28 February 2009
2. EMCDDA, Europol (2007) Joint report on a new psychoactive substance: 1-(3-chlorphenyl)piperazine (mCPP). http://www.emcdda.europa.eu/themes/new- drugs/early-warning. Accessed 28 February 2009
3. A Hamik SJ Peroutka 1989 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain Biol Psychiatry 25 569 575 1:CAS:528:DyaL1MXhsVOkurg%3D 10.1016/0006-3223(89)90217-5 2537663 (Pubitemid 19071308)
4. E Eriksson G Engberg O Bing H Nissbrandt 1999 Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain Neuropsychopharmacology 20 287 296 1:CAS:528:DyaK1MXhsleis7w%3D 10.1016/S0893-133X(98)00070-0 10063489 (Pubitemid 29067408)
5. ME Tancer CE Johanson 2001 The subjective effects of MDMA and mCPP in moderate MDMA users Drug Alcohol Depend 65 97 101 1:CAS:528:DC%2BD3MXosFKrurg%3D 10.1016/S0376-8716(01)00146-6 11714594 (Pubitemid 33063665)
6. HH Maurer T Kraemer D Springer RF Staack 2004 Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis Ther Drug Monit 26 127 131 1:CAS:528:DC%2BD2cXjvFOktbw%3D 10.1097/00007691-200404000-00007 15228152 (Pubitemid 38501205)
7. CE Johanson M Kilbey K Gatchalian M Tancer 2006 Discriminative stimulus effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo Drug Alcohol Depend 81 27 36 1:CAS:528:DC%2BD2MXht1Onur7E 10.1016/j.drugalcdep.2005. 05.003 15975736 (Pubitemid 41682476)
8. T Klaassen KL Ho Pian HG Westenberg JA den Boer HM van Praag 1998 Serotonin syndrome after challenge with the 5-HT agonist meta- chlorophenylpiperazine Psychiatry Res 79 207 212 1:CAS:528:DyaK1cXltlChurc%3D 10.1016/S0165-1781(98)00044-4 9704867 (Pubitemid 28346468)
9. V Fineschi A Masti 1996 Fatal poisoning by MDMA (ecstasy) and MDEA: a case report Int J Legal Med 108 272 275 1:STN:280:DyaK283osFyrsw%3D%3D 10.1007/BF01369826 8721431 (Pubitemid 26111269)
10. K Libiseller M Pavlic P Grubwieser W Rabl 2007 An announced suicide with ecstasy Int J Legal Med 121 40 43 10.1007/s00414-005-0039-9 16175411 (Pubitemid 46009471)
11. EA De Letter WE Lambert MP Bouche JA Cordonnier JF Van Bocxlaer MH Piette 2007 Postmortem distribution of 3, 4-methylenedioxy-N, N-dimethyl-amphetamine (MDDM or MDDA) in a fatal MDMA overdose Int J Legal Med 121 303 307 10.1007/s00414-006-0094-x 16636864 (Pubitemid 46800801)
12. MG Bossong JP Van Dijk RJ Niesink 2005 Methylone and mCPP, two new drugs of abuse? Addict Biol 10 321 323 1:CAS:528:DC%2BD2MXht1Glt7jP 10.1080/13556210500350794 16318952 (Pubitemid 41759265)
13. Bundesgesetzblatt Jahrgang 2007 Teil I Nr. 5, Zwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften-20. BtMÄndV vom 14.02.2007
14. Pütz M, Martin N (2008) Application of CE-ESI-MS in forensic toxicology: Identification of piperazine-derived designer drugs in Ecstasy tables and of food colorants in illicit drugs. In: Pragst F, Aderjan R (ed) XV. GTFCh-Symposium 2007 Aktuelle Beiträge zur Forensischen und Klinischen Toxikologie, Bad Vibel, pp. 487-501
15. D De Boer IJ Bosman E Hidvegi C Manzoni AA Benko LJ dos Reys RA Maes 2001 Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market Forensic Sci Int 121 47 56 10.1016/S0379-0738(01)00452-2 11516887 (Pubitemid 32758813)
16. RF Staack HH Maurer 2003 Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone J Anal Toxicol 27 560 568 1:CAS:528:DC%2BD3sXoslOju78%3D 14670134
17. FT Peters S Schaefer RF Staack T Kraemer HH Maurer 2003 Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry J Mass Spectrom 38 659 676 1:CAS:528: DC%2BD3sXltlSksL4%3D 10.1002/jms.483 12827635 (Pubitemid 36818224)
18. W Weinmann M Renz S Vogt S Pollak 2000 Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS Int J Legal Med 113 229 235 1:STN:280:DC%2BD3M%2FktFGktA%3D%3D 10.1007/s004149900098 10929239
19. SC Bishop BR McCord SR Gratz JR Loeliger MR Witkowski 2005 Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector J Forensic Sci. 50 326 335 1:CAS:528:DC%2BD2MXivFKms7c%3D 10.1520/JFS2004239 15813543
20. M Frost H Kohler G Blaschke 1996 Analysis of "ecstasy" by capillary electrophoresis Int J Legal Med 109 53 57 1:STN:280: DyaK2s%2FmvVymuw%3D%3D 10.1007/BF01355516 8912047 (Pubitemid 26342836)
21. T Nagai S Kamiyama T Nagai 1988 Forensic toxicologic analysis of methamphetamine and amphetamine optical isomers by high performance liquid chromatography Z Rechtsmed 101 151 159 1:STN:280:DyaL1M7kslehuw%3D%3D 10.1007/BF00201110 3227723
22. T Sokoliess J Schönherr U Menyes U Roth T Jira 2003 Characterization of calixarene- and resorcinarene-bonded stationary phases. I. Hydrophobic interactions J Chromatogr A 1021 71 82 1:CAS:528:DC%2BD3sXos12rtLY%3D 10.1016/j.chroma.2003.09.014 14735976 (Pubitemid 37357013)
23. RVS Nirogi S Kota BG Peruri VN Kandikere K Mudigonda 2006 Chiral high-performance liquid chromatographic method for enantioselective analysis of zaltoprofen Acta Chromatogr 17 202 209 1:CAS:528:DC%2BD2sXislShsb8%3D
24. SM Wille EA De Letter MH Piette LK Van Overschelde CH Van Peteghem WE Lambert 2009 Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry Int J Legal Med 123 451 458 10.1007/s00414-008-0287-6 18839201
25. M Abondo R Bouvet A Baert I Morel M Le Gueut 2009 Sexual assault and MDMA: the distinction between consciousness and awareness when it comes to consent Int J Legal Med 123 155 156 1:STN:280:DC%2BD1M7jslGlsg%3D%3D 10.1007/s00414-008-0305-8 19101717